Uniqure NV (QURE) Reaches $11.67 After 4.00% Down Move; Americas Carmart Has 0.77 Sentiment

October 17, 2017 - By Kurt Siggers

The stock of Uniqure NV (NASDAQ:QURE) is a huge mover today! The stock decreased 2.59% or $0.31 during the last trading session, reaching $11.67. About 324,622 shares traded or 96.46% up from the average. Uniqure NV (NASDAQ:QURE) has declined 52.65% since October 17, 2016 and is downtrending. It has underperformed by 69.35% the S&P500.The move comes after 6 months negative chart setup for the $299.09 million company. It was reported on Oct, 17 by Barchart.com. We have $11.20 PT which if reached, will make NASDAQ:QURE worth $11.96 million less.

America’s Car-Mart, Inc. is an automotive retailer focused on the integrated auto sales and finance segment of the used car market. The company has market cap of $307.90 million. The Firm conducts its activities through its two operating subsidiaries, America’s Car Mart, Inc. and Colonial Auto Finance, Inc. (Colonial) (Collectively, Car-Mart of Arkansas and Colonial are referred to as Car-Mart). It has a 16.57 P/E ratio. It primarily sells older model used vehicles and provides financing for all of its customers.

Among 12 analysts covering uniQure N.V. (NASDAQ:QURE), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. uniQure N.V. has $60 highest and $8 lowest target. $30.45’s average target is 160.93% above currents $11.67 stock price. uniQure N.V. had 25 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating by Zacks given on Tuesday, September 1. Janney Capital initiated the shares of QURE in report on Tuesday, December 1 with “Buy” rating. The firm has “Buy” rating given on Wednesday, June 28 by Oppenheimer. The firm has “Buy” rating by Piper Jaffray given on Monday, September 21. On Friday, August 28 the stock rating was maintained by Piper Jaffray with “Overweight”. The company was downgraded on Tuesday, November 22 by Jefferies. The firm has “Buy” rating given on Wednesday, July 12 by Cowen & Co. On Monday, November 30 the stock rating was reinitiated by Roth Capital with “Buy”. As per Monday, September 21, the company rating was maintained by Oppenheimer. The firm earned “Buy” rating on Monday, November 30 by TH Capital.

Analysts await Uniqure NV (NASDAQ:QURE) to report earnings on November, 28. They expect $-0.80 EPS, down 33.33% or $0.20 from last year’s $-0.6 per share. After $-0.83 actual EPS reported by Uniqure NV for the previous quarter, Wall Street now forecasts -3.61% EPS growth.

Uniqure NV is a gene therapy company based in the Netherlands. The company has market cap of $299.09 million. The Firm is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. It currently has negative earnings. The Firm advances a focused pipeline of gene therapies that are developed both internally and through partnerships.

Analysts await America’s Car-Mart, Inc. (NASDAQ:CRMT) to report earnings on November, 16. They expect $0.82 EPS, up 32.26% or $0.20 from last year’s $0.62 per share. CRMT’s profit will be $6.04M for 12.74 P/E if the $0.82 EPS becomes a reality. After $0.90 actual EPS reported by America’s Car-Mart, Inc. for the previous quarter, Wall Street now forecasts -8.89% negative EPS growth.

Bares Capital Management Inc. holds 1.32% of its portfolio in America’s Car-Mart, Inc. for 763,514 shares. Horrell Capital Management Inc. owns 27,941 shares or 0.64% of their US portfolio. Moreover, Nantahala Capital Management Llc has 0.26% invested in the company for 84,214 shares. The Missouri-based Kennedy Capital Management Inc. has invested 0.22% in the stock. Jupiter Asset Management Ltd, a United Kingdom-based fund reported 145,249 shares.

About 21,465 shares traded. America’s Car-Mart, Inc. (CRMT) has risen 53.64% since October 17, 2016 and is uptrending. It has outperformed by 36.94% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com